| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| CN¥0.20 | -9.05% | ||
| CN¥0.20 | -9.05% | ||
| CN¥0.2199 | -33.08% | ||
| CN¥0.2199 | -33.08% | ||
| CN¥0.3286 | -6.7% | ||
| CN¥0.3522 | 118.49% | ||
| CN¥0.1612 | 130.29% | ||
| CN¥0.07 | |||
Pharmaron Beijing Co Ltd - Class H pays a dividend yield (FWD) of 1.33%.
- ISIN
- WKN
- Symbol / Exchange
- / XHKG
- Value
- €1.69
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Chinese Yuan
- Earnings Date
- Within the last 12 months, Pharmaron Beijing Co Ltd - Class H paid a dividend of CN¥0.22. For the next 12 months, Pharmaron Beijing Co Ltd - Class H is expected to pay a dividend of CN¥0.19. This corresponds to a dividend yield of approximately 1.33%.
- The dividend yield of Pharmaron Beijing Co Ltd - Class H is currently 1.33%.
- Pharmaron Beijing Co Ltd - Class H pays annually dividends. Payout is in July.
- The next dividend will be paid on 6 August 2025.
- Within the last 10 years, Pharmaron Beijing Co Ltd - Class H has paid dividends in 5 of them.
- Dividends of CN¥0.19 are expected for the next 12 months. This corresponds to a dividend yield of 1.33%.
- Pharmaron Beijing Co Ltd - Class H is assigned to the sector "Health Care".
- The last stock split of Pharmaron Beijing Co Ltd - Class H was on 18 July 2023 in the ratio 15:10.
- In order to receive the future dividend from Pharmaron Beijing Co Ltd - Class H on 6 August 2025 you must have purchased your Pharmaron Beijing Co Ltd - Class H shares before the ex-date on 4 July 2025.
- To receive the last dividend of Pharmaron Beijing Co Ltd - Class H on 26 July 2024 in the amount of HK$0.22 you had to have the stock in your portfolio before the ex-day on 27 June 2024.
- The last dividend was paid on 26 July 2024.
- In 2022, dividends of CN¥0.35 were paid by Pharmaron Beijing Co Ltd - Class H.
- Dividends from Pharmaron Beijing Co Ltd - Class H are paid in Chinese Yuan.
- The headquarters of Pharmaron Beijing Co Ltd - Class H is located in China.